INTRODUCTION {#sec1-1}
============

We report a case of complex maxillofacial injury with avulsion of the soft tissue, which was treated in a more conservative manner that avoided many of the complications.\[[@ref1]\] The case was that of a 39-year-old female who presented to the emergency department 8 days after being involved in a motor vehicle accident, which had caused a severe disruption of the soft tissue architecture of the left face associated with a malodorous septic wound consisting of loose bone fragments, grass, pieces of glass, stone, and sand \[[Figure 1](#F1){ref-type="fig"}\].

![Wound on presentation](AMS-3-87-g001){#F1}

Clinical examination suggested a fracture of the left lateral orbital margin. There were no cranial nerve defects. Because of the severe degree of contamination, radical debridement would have required to put the wound into bacterial balance to allow successful closure. This would have necessitated the undesirable removal of the exposed superficial nerve branches.

We elected to do minimal debridement of the soft tissue and perform reduction and fixation of the orbital rim to reestablish facial contour. A new hydrocunductive dressing Drawtex (SteadMed Medical, LLC. Fort Worth, Texas 76102) was used to treat the soft tissue wound. This dressing has been demonstrated to remove exudate, debris, bacteria, biofilm, and cytokines deleterious to wound healing.\[[@ref2]--[@ref5]\] The Drawtex dressing was initially changed daily and the frequency was decreased as the wound improved \[Figures [2a](#F2){ref-type="fig"}-[d](#F2){ref-type="fig"} and [3a](#F3){ref-type="fig"}-[c](#F3){ref-type="fig"}\].

![Wound healing after successive dressing changes from Day 15 to 30](AMS-3-87-g002){#F2}

![Representation of progressive healing, structure of drawtex](AMS-3-87-g003){#F3}

Serial photographs, wound measurements, and Elixr analyses were performed. Wound bed analysis from photographic images was done (Imago Care Ltd, London, UK). Elixr is a statistical pattern-recognition algorithm that classifies each wound color pixel in a wound image, providing a documented area measurement variance of only 1% (with flat wound images) to 5% (with rounded wound images) was used. It also divides a wound into three tissue type classifications: Necrotic tissue is represented in black color; fibrin and slough in yellow; and granulation tissue in red in a digitized wound photograph. Accurate readings of granulation, slough and eschar found in the wound bed were recorded \[Figures [4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}\].

![Wound gallery analysis (Yellow = slough, Black = Eschar, Red = granulation)](AMS-3-87-g004){#F4}

![Tissue analysis graph (Yellow = slough, Black = Eschar, Red = granulation)](AMS-3-87-g005){#F5}

The wound trajectory progressed to total healing by the 33^rd^ day. No further debridement of the soft tissue was required. Patient was subsequently lost to long-term follow-up when she failed to return and efforts to locate her were unsuccessful.

DISCUSSION {#sec1-2}
==========

Hydroconductive dressings are a new class of wound dressing developed to aid wound healing.\[[@ref6]\] Drawtex is composed of a combination of two types of absorbent, cross-action structure that creates the ability to move large volumes of fluid, debris, and other deterrents to healing from the wound and into the dressing. This hydroconductive action allows the dressing to lift, hold, and transfer the wound exudate both horizontally and vertically. Even when completely saturated, the Drawtex dressing maintains its integrity, stays in place and remains intact so it can be easily removed in one piece. No dressing particles are left in the wound.

This case report demonstrates the use of a new hydroconductive dressing to perform many of the functions of surgical debridement. In this case, it allowed the wound to progress with minimum loss of soft tissue, without losing structures such as superficial peripheral nerves, and negated the need for tertiary wound closure by a pedicle flap or skin graft.
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